Cross Country Healthcare Stock Price To Earnings To Growth
| XXY Stock | EUR 17.10 0.10 0.58% |
Cross Country Healthcare fundamentals help investors to digest information that contributes to Cross Country's financial success or failures. It also enables traders to predict the movement of Cross Stock. The fundamental analysis module provides a way to measure Cross Country's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Cross Country stock.
Cross |
Cross Country Healthcare Company Price To Earnings To Growth Analysis
Cross Country's PEG Ratio indicates the potential value of an equity instrument and is calculated by dividing Price to Earnings (P/E) ratio into earnings growth rate. Most analysts and investors prefer this measure to a Price to Earnings (P/E) ratio because it incorporates the future growth of a firm. The low PEG ratio usually implies that an equity instrument is undervalued; whereas PEG of 1 may indicate that an equity is reasonably priced under given expectations of future growth.
Current Cross Country Price To Earnings To Growth | 0.96 X |
Most of Cross Country's fundamental indicators, such as Price To Earnings To Growth, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cross Country Healthcare is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, PEG ratio is a 'quick and dirty' way to measure how the current price of a firm's stock relates to its earnings and growth rate. The main benefit of using PEG ratio is that investors can compare the relative valuations of companies within different industries without analyzing their P/E ratios.
| Competition |
Based on the latest financial disclosure, Cross Country Healthcare has a Price To Earnings To Growth of 0.9619 times. This is 27.68% lower than that of the Industrials sector and 10.1% lower than that of the Staffing & Outsourcing Services industry. The price to earnings to growth for all Germany stocks is 80.33% higher than that of the company.
Did you try this?
Run Portfolio Backtesting Now
Portfolio BacktestingAvoid under-diversification and over-optimization by backtesting your portfolios |
| All Next | Launch Module |
Cross Fundamentals
| Return On Equity | 0.5 | |||
| Return On Asset | 0.21 | |||
| Profit Margin | 0.07 % | |||
| Operating Margin | 0.10 % | |||
| Current Valuation | 1.18 B | |||
| Shares Outstanding | 36.82 M | |||
| Shares Owned By Insiders | 5.37 % | |||
| Shares Owned By Institutions | 99.85 % | |||
| Price To Earning | 6.82 X | |||
| Price To Book | 2.66 X | |||
| Price To Sales | 0.35 X | |||
| Revenue | 2.81 B | |||
| Gross Profit | 627.69 M | |||
| EBITDA | 283.29 M | |||
| Net Income | 188.46 M | |||
| Cash And Equivalents | 24.83 M | |||
| Cash Per Share | 0.67 X | |||
| Total Debt | 148.74 M | |||
| Debt To Equity | 59.00 % | |||
| Current Ratio | 1.99 X | |||
| Book Value Per Share | 12.60 X | |||
| Cash Flow From Operations | 134.05 M | |||
| Earnings Per Share | 5.67 X | |||
| Price To Earnings To Growth | 0.96 X | |||
| Target Price | 20.71 | |||
| Number Of Employees | 2.7 K | |||
| Beta | 1.05 | |||
| Market Capitalization | 925.43 M | |||
| Total Asset | 947.84 M | |||
| Z Score | 5.6 | |||
| Net Asset | 947.84 M |
About Cross Country Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Cross Country Healthcare's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cross Country using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cross Country Healthcare based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Cross Stock
When determining whether Cross Country Healthcare offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cross Country's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cross Country Healthcare Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cross Country Healthcare Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Cross Country Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.